AIR LIQUIDE -1% Q1 revenues miss, AIRGAS deal on track, outlook reiterated.
AIXTRON +2% Earnings miss but v low expectations, , guidance reiterated.
BATS +2% Q1 revenues +7.5% v +5.1% exp. Volumes ahead, strong H2 exp.
BAYER +2% Q1 ahead across the board, strong XARELTO sales, new drugs beat
BP +2% Q1 positive, adj net income ahead on Downstream beat. Call @ 2pm
CASINO 0% CNOVA review update, EBIT ahead but further issues identified.
COBHAM -15% Warning, trading profits @ £15m v £50m exp. - £500m rts issue
DSM +2% Q1 profit beat, Nutrition ahead, US mkt slow, maintain outlook
ORANGE +1% Q1 revenues inline, EBITDA flat, no discussion with KPN/ZAIN
PETRA D. -2% Q3 IMS light due to weakness @ Cullinan.
RANDSTAD 0% Q1 EBITDA inline, org gorwth +5%, GM flat, geographically inline
SAB MILLER -1% Kulczyk placing half their holding (24m shrs) @ 4180
SAFRAN +1% Q1'16 adj revenues inline, LEAP on track, no ZODIAC comment
SALZGITTER -4% Q1 sales and earnings light as expected, sector down overnight
SWEDBANK -2% Q1 pre-tax miss, total rev miss, NII small miss v consensus.
TELEFONICA -2% EU Anti-trust regulator to block Huchison's O2 deal
THALES +2% Own 35% of DCNS, contract win to build submarines, Australia.
THYSSENKRUP -4% Loses bid to build 12 Submarines for Australia, sector weakness
UMICORE 0% Q1 trading update bang inline, but enough?
WHITBREAD 0% Inline update, positive COSTA sales, reiterate outlook